• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

    0.2087 -0.0363 (-14.82%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Aspire Biopharma Holdings, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    What's going on in today's after hours session ↗
    Via Chartmill
    Monday's session: most active stocks ↗
    Via Chartmill
    News headline image
    Aspire Biopharma Announces $5.0 Million Share Repurchase Program
    Via ACCESS Newswire
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    Top movers in Tuesday's session ↗
    Via Chartmill
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue
    Via ACCESS Newswire
    News headline image
    These stocks are moving in today's session ↗
    Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    Here are the top movers in Wednesday's session. ↗
    Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    These stocks are moving in today's pre-market session ↗
    Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    Topics Artificial Intelligence
    News headline image
    Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion
    Via ACCESS Newswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Wednesday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
    Via ACCESS Newswire
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma's Buzz Bomb Caffeine Company Names ChicExecs as Public Relations Agency of Record
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))
    Via ACCESS Newswire
    News headline image
    Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements
    Via ACCESS Newswire
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.